Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-01-28
1992-08-11
Rollins, John W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514468, 514822, A61K 31335, A61K 3134
Patent
active
051379120
ABSTRACT:
This invention refer to chelerythrine, a considerably effective drug in the prevention and therapy of the thrombosis, which is a quaternary amine derivative and a major component of the organic solvent soluble extract of Zanthoxylum simulans. The effects of chelerythrine on the thromboembolism and the constriction of the blood vessel are also examined.
REFERENCES:
patent: 4590061 (1986-05-01), Southard
patent: 4767626 (1988-08-01), Cheng
Chem. Abstr. 113(9):71037e, 1990.
The March Index 9th ed. p. 257, No. 2007, 1976.
Chen Ih-Sheng
Huang Tur-Fu
Ko Feng-Nien
Teng Che-Ming
Wu Shwu-Jen
National Science Council of Republic of China
Rollins John W.
LandOfFree
Chelerythrine inhibits platelet aggregation--a potential anti-ag does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chelerythrine inhibits platelet aggregation--a potential anti-ag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chelerythrine inhibits platelet aggregation--a potential anti-ag will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-346688